| Company | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
|---|---|---|---|---|---|---|---|
| Fusion Pharmaceuticals Inc. | Chief Technology Officer | Common Stock | 0 | $0 | $2.03 | 04 Jun 2024 | Direct |
| Fusion Pharmaceuticals Inc. | Chief Technology Officer | Restricted Stock Units | 0 | $0 | $2.03 | 04 Jun 2024 | Direct |
| Fusion Pharmaceuticals Inc. | Chief Technology Officer | Stock Option (Right to Buy) | 0 | 04 Jun 2024 | Direct |
| Symbol | Company | Period | Transactions | Value $ | Form Type | Role | Filing Time |
|---|---|---|---|---|---|---|---|
| /report/000095017024068881-burak-eric-2024-06-04 | Fusion Pharmaceuticals Inc. | 04 Jun 2024 | 15 | $0 | 4 | Chief Technology Officer | 04 Jun 2024, 17:21 |
| /report/000095017024002297-burak-eric-2024-01-04 | Fusion Pharmaceuticals Inc. | 04 Jan 2024 | 2 | $0 | 4 | Chief Technology Officer | 05 Jan 2024, 08:51 |
| /report/000120919123002495-burak-eric-2023-01-05 | Fusion Pharmaceuticals Inc. | 05 Jan 2023 | 1 | $0 | 4 | Chief Technology Officer | 09 Jan 2023, 05:43 |
| /report/000120919122007046-burak-eric-2022-02-01 | Fusion Pharmaceuticals Inc. | 01 Feb 2022 | 1 | $0 | 4 | Chief? Scientific Officer | 03 Feb 2022, 18:36 |